FBRX Stock Summary and Trading Ideas (Forte Biosciences | NASDAQ:FBRX)

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).

Forte Biosciences trades on the NASDAQ stock market under the symbol FBRX.

As of March 4, 2025, FBRX stock price declined to $7.21 with 6,510 million shares trading.

FBRX has a beta of 1.49, meaning it tends to be more sensitive to market movements. FBRX has a correlation of 0.02 to the broad based SPY ETF.

FBRX has a market cap of $46.10 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, FBRX traded as high as $39.75 and as low as $4.11.

The top ETF exchange traded funds that FBRX belongs to (by Net Assets): VTI, ATFV, VXF, ONEQ.

FBRX has underperformed the market in the last year with a price return of -60.1% while the SPY ETF gained +13.9%. FBRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -70.0% and -39.9%, respectively, while the SPY returned -4.2% and -5.4%, respectively.

FBRX support price is $6.82 and resistance is $8.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBRX shares will trade within this expected range on the day.